@misc
{TN_libero_mab2,
author = {
Eisert, Wolfgang G.
},
title = {
Dipyridamole in antithrombotic treatment
},
edition = {
published Version
}
,
publisher = {S. Karger},
keywords = {
priority journal
,
tissue injury
,
thromboembolism
,
Platelet Aggregation Inhibitors
,
acetylsalicylic acid
,
anticoagulant agent
,
coronary artery atherosclerosis
,
bleeding
,
vasodilatation
,
antiinflammatory activity
,
coronary artery blood flow
,
Humans
,
PAR-1
,
hemostasis
,
article
,
antioxidant activity
,
oxidative stress
,
drug mechanism
,
dipyridamole
,
adenosine
,
Blood Platelets
,
sustained release formulation
,
prostacyclin
,
thrombocyte aggregation inhibition
,
human
,
Receptor
,
drug blood level
,
anticoagulant therapy
,
Thrombin
,
vascular patency
,
Phosphodiesterase 5 Inhibitors
,
thrombosis
,
metabolic stress
,
atherosclerotic plaque
,
acetylsalicylic acid plus dipyridamole
,
thrombosis prevention
},
year = {2012},
abstract = {Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.},
booktitle = {Advances in Cardiology 47 (2012)},
url = {
http://slubdd.de/katalog?TN_libero_mab2
}
}